BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 7515672)

  • 1. Influence of fixation and preparation on the AgNOR distribution in routinely processed breast cancer specimens.
    Biesterfeld S; Ruoss E; Hufnagl P; Martin H
    Zentralbl Pathol; 1994 Mar; 140(1):41-8. PubMed ID: 7515672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
    Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
    J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleolar organizer regions in human breast cancer.
    Roller E; Fritz P; Wicherek C; Klumpp B; Lauinger J; Mischlinski A; Wanner B; Schumacher K
    Zentralbl Pathol; 1993 Aug; 139(3):195-9. PubMed ID: 8218120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleolar organizer regions distribution in fine needle aspiration cytological smears from breast lesions.
    Hasnan J; Jayaram G
    Malays J Pathol; 1996 Jun; 18(1):35-41. PubMed ID: 10879223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic value of AgNORs in breast cancer].
    Aubele M; Auer G; Jütting U
    Zentralbl Pathol; 1994 Mar; 140(1):55-60. PubMed ID: 7515674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wet autoclave pretreatment improves the visualization of silver-stained nucleolar organizer-region-associated proteins in routinely formalin-fixed and paraffin-embedded tissues.
    Ofner D; Bankfalvi A; Riehemann K; Bier B; Böcker W; Schmid KW
    Mod Pathol; 1994 Dec; 7(9):946-50. PubMed ID: 7892164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of significance of AgNOR counts in differentiating benign from malignant lesions in the breast.
    Dube MK; Govil A
    Indian J Pathol Microbiol; 1995 Jan; 38(1):5-10. PubMed ID: 8919463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardized demonstration of silver-stained nucleolar organizer regions-associated proteins in archival oral squamous cell carcinomas and adjacent non-neoplastic mucosa.
    Piffkò J; Bànkfalvi A; Ofner D; Rasch D; Joos U; Schmid KW
    Mod Pathol; 1997 Feb; 10(2):98-104. PubMed ID: 9127314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative activity is a significant prognostic factor in male breast carcinoma.
    Pich A; Margaria E; Chiusa L
    Am J Pathol; 1994 Aug; 145(2):481-9. PubMed ID: 7519830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AgNORs in ductal breast cancer: correlation with ploidy and S-phase fraction by DNA flow cytometry.
    Borgiani L; Cogorno P; Oliviero J; Toso F; Gambini G; Tunesi G; Canepa M
    Eur J Histochem; 1994; 38(2):171-6. PubMed ID: 7524814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of AgNORS in fine needle aspiration cytology of breast lesions.
    Rajeevan K; Aravindan KP; Kumari BC
    Indian J Pathol Microbiol; 1995 Jan; 38(1):17-24. PubMed ID: 8919465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma.
    Chen TL; Luo I; Mikhail N; Rasková J; Raska K
    Cytometry; 1995 Sep; 22(3):181-9. PubMed ID: 8556949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical significance of AgNOR counts in FNAC smears and corresponding histopathological sections.
    Mehrotra A; Chandra T
    Indian J Exp Biol; 1998 Feb; 36(2):162-6. PubMed ID: 9754045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Argyrophilic nuclear organizer regions in nasopharyngeal carcinoma and paraneoplastic epithelia.
    Chen M; Lee JC; Lo S; Shen J
    Head Neck; 2003 May; 25(5):395-9. PubMed ID: 12692877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardized in situ AgNOR analysis in breast pathology: diagnostic and cell kinetic implications.
    Bànkfalvi A; Ofner D; Schmid KW; Schmitz KJ; Breukelmann D; Krech R; Böcker W
    Pathol Res Pract; 1999; 195(4):219-29. PubMed ID: 10337659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of quantitatively measured AgNORs in ductal mammary carcinoma.
    Aubele M; Auer G; Jütting U; Falkmer U; Gais P
    Anal Quant Cytol Histol; 1994 Jun; 16(3):211-8. PubMed ID: 7522453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
    Pich A; Chiusa L; Margaria E
    Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential quantification of AgNOR area and number during silver staining by means of an image analysing system.
    Ofner D; Hittmair A; Maier H; Riedmann B; Rumer A; Lucciarini P; Offner F; Mikuz G; Schmid KW
    Zentralbl Pathol; 1994 Mar; 140(1):37-40. PubMed ID: 7515671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silver-binding nucleolar organizer regions (AgNORs) in benign and malignant breast lesions: correlations with ploidy and growth phase by DNA flow cytometry.
    Giri DD; Nottingham JF; Lawry J; Dundas SA; Underwood JC
    J Pathol; 1989 Apr; 157(4):307-13. PubMed ID: 2715879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of AgNORs in pulmonary lesions: a cyto-histopathological correlation.
    Gulati A; Sharma J; Sharma BB; Kaushik R; Kashyap S
    Indian J Pathol Microbiol; 2002 Jul; 45(3):289-92. PubMed ID: 12785168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.